Recent rodent studies from our laboratory and others reported that the expression of intestinal Reg3γ is downregulated in metabolic disorders induced by nutrition (high-fat diet, alcohol) or genetic modification (ob/ob, db/db) that result in obesity and impaired glucose regulation. Here, REG3G is linked to metabolic disease.